Literature DB >> 2984971

Hematologic malignancies associated with primary mediastinal germ-cell tumors.

C R Nichols, R Hoffman, L H Einhorn, S D Williams, L A Wheeler, M B Garnick.   

Abstract

Three men with primary mediastinal germ-cell tumors subsequently developed a malignant hematologic disorder characterized by pancytopenia and marrow infiltration with hematopoietic blast cells. Two of these patients were classified as having acute megakaryocytic leukemia and the third was believed to have a myelodysplastic syndrome with a prominent megakaryocytic component. Analysis of clinical characteristics of these patients and review of the literature suggest that the proximate association of mediastinal germ-cell tumors with malignant hematologic disorders is neither a coincidence nor a consequence of chemotherapy given for the germ-cell tumor. We believe this association represents the evolution of a neoplastic disorder that initially involves a totipotent germ cell. These germ cells, when located in the mediastinum, apparently acquire hematologic phenotypes and are manifested clinically as a hematologic malignancy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984971     DOI: 10.7326/0003-4819-102-5-603

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  30 in total

Review 1.  Why are hematopoietic stem cells so 'sexy'? on a search for developmental explanation.

Authors:  M Z Ratajczak
Journal:  Leukemia       Date:  2017-05-15       Impact factor: 11.528

2.  Malignant transformations in a patient with a mediastinal germ cell tumour: lack of efficacy of bone marrow transplantation after chemotherapy on tumour recurrence.

Authors:  Yusra Kassim; Dominique Penther; Pascale Schneider; Marie-Paul Callat; Christian Bastard; Jean-Pierre Vannier
Journal:  BMJ Case Rep       Date:  2012-06-14

3.  Acute leukemia associated with mediastinal germ cell tumor. De novo versus therapy-related leukemia.

Authors:  Y K Keung; R Liang; E K Chiu
Journal:  West J Med       Date:  1993-04

4.  Long-term outcomes of pediatric and adolescent mediastinal germ cell tumors: a single pediatric oncology institutional experience.

Authors:  D F Grabski; A S Pappo; M J Krasin; A M Davidoff; B N Rao; I Fernandez-Pineda
Journal:  Pediatr Surg Int       Date:  2016-11-12       Impact factor: 1.827

Review 5.  Biology of metastases and its clinical implications: testicular germ-cell tumors.

Authors:  J P Donohue; R S Foster; J S Little; P J Loehrer; L E Einhorn
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

6.  Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy.

Authors:  J S Little; R S Foster; T M Ulbright; J P Donohue
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Langerhans' cell histiocytosis: possible association with malignant germ cell tumour.

Authors:  W K Ng; K Y Lam; I O Ng
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

Review 8.  Pluripotent stem cells and their niches.

Authors:  M William Lensch; Laurence Daheron; Thorsten M Schlaeger
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

9.  Non-seminomatous germ-cell tumour associated with acute megakaryoblastic leukaemia.

Authors:  D Dopico Vázquez; María I Gallegos Sancho; G Alonso Curbera; A Carral Maseda; M Quindós Varela; L M Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

10.  Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.

Authors:  Justin Taylor; Mark Ta Donoghue; Caleb Ho; Kseniya Petrova-Drus; Hikmat A Al-Ahmadie; Samuel A Funt; Yanming Zhang; Umut Aypar; Pavitra Rao; Shweta S Chavan; Michael Haddadin; Roni Tamari; Sergio Giralt; Martin S Tallman; Raajit K Rampal; Priscilla Baez; Rajya Kappagantula; Satyajit Kosuri; Ahmet Dogan; Satish K Tickoo; Victor E Reuter; George J Bosl; Christine A Iacobuzio-Donahue; David B Solit; Barry S Taylor; Darren R Feldman; Omar Abdel-Wahab
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.